Loading clinical trials...
Loading clinical trials...
Transthyretin cardiac amyloidosis (TTR-CA) is a heart disease that mainly affects older adults and often leads to reduced physical capacity, muscle weakness, frailty, and a decline in quality of life....
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Universidad de Burgos
Collaborators
NCT05797857 · Amyloid Cardiomyopathy, Transthyretin Cardiac Amyloidosis
NCT05772091 · Transthyretin Cardiac Amyloidosis
NCT06328075 · Amyloid Cardiomyopathy, Transthyretin Amyloid Cardiomyopathy, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions